Evidence map›Paper›PMID 19819272›Full record

ArticleNeuroscience research2010

Negative symptoms of schizophrenia correlate with impairment on the University of Pennsylvania smell identification test.

Koko Ishizuka, Katsunori Tajinda, Carlo Colantuoni, Masahiko Morita, Jessica Winicki, Cindy Le, Sandra Lin, David Schretlen, Akira Sawa, Nicola G Cascella

Abstract read
In one paragraph

Article in Neuroscience research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Evaluation of Nasal Mucociliary Clearance Time in Patients with Schizophrenia.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  6. Unraveling the Link between Olfactory Deficits and Neuropsychiatric Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  7. Olfactory Dysfunction in Mental Illness.Current allergy and asthma reports · 2023
    Review
  8. Brain regions associated with olfactory dysfunction in first episode psychosis patients.The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Koko IshizukaDepartment of Psychiatry, Johns Hopkins University School of Medicine, United States.
Katsunori Tajinda
Carlo Colantuoni
Masahiko Morita
Jessica Winicki
Cindy Le
Sandra Lin
David Schretlen
Akira Sawa
Nicola G Cascella
Johns Hopkins University · USJohns Hopkins Medicine · USAstellas Pharma (Japan) · JP

Funding

Research Center for Molecular Pathogenesis of SchizophreniaP20MH084018 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2008 to 2010
$3.3M
Nuclear pathway of DISC1 in major mental illnesses: biochemistry and cell biologyR01MH069853 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2004 to 2012
$3.2M
NIMH NIH HHS MH-069853NIMH NIH HHS MH-084018NIMH NIH HHS P20 MH084018NIMH NIH HHS R01 MH069853
6 · The paper itself

Abstract

Deficits in odor identification have been most frequently described in schizophrenia (SZ). A relationship between dysfunction in odor identification and negative symptoms of SZ has also been reported. Furthermore, deficit SZ (a subtype of the illness with primary, enduring negative symptoms) has been found to be associated with a particularly poor performance on odor identification tests indicating that deficits in smell identification could be differentially expressed in some subtypes of SZ. We describe correlations of performance on smell identification with positive and negative symptoms of SZ. Patients with SZ (n=15) and normal controls (n=19) were tested by the University of Pennsylvania Smell Identification Test (UPSIT). Psychopathology was assessed with the Scales for the Assessment of Positive and Negative Symptoms (SAPS and SANS). SZ patients performed more poorly on the UPSIT test than did normal controls. Consistent with previous findings, we observed a correlation of SANS with UPSIT performance. In particular, specific subdomains of SANS, such as blunted affect, apathy and anhedonia, were associated with odor identification deficits. Furthermore, UPSIT score predicts these subdomains of negative symptoms. No correlation was observed between positive symptom and odor identification deficits. Our study further reinforces a relation between olfactory identification deficit and negative symptoms in SZ and suggests that smell identification could be a candidate endophenotype relevant to negative symptoms of SZ.

Indexed as

Neuropsychological TestsAdultChi-Square DistributionFemaleHumansMaleMiddle AgedOdorantsOlfaction DisordersPsychiatric Status Rating ScalesRegression AnalysisSchizophreniaSmellTime Factors

Identifiers

PMID19819272
PMCPMC4064297
OpenAlexW2060294677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.